A. Glunz
University of Duisburg-Essen · 6 works · 404 citations · h-index 6
Top works
- BEACOPP, a new dose-escalated and accelerated regimen, is at least as effective as COPP/ABVD in patients with advanced-stage Hodgkin's lymphoma: interim report from a trial of the German Hodgkin's Lymphoma Study Group.
- Impact of risk factors on outcomes in early-stage Hodgkin's lymphoma: an analysis of international staging definitions
- BEACOPP: A new regimen for advanced Hodgkin’s disease
- Treatment of advanced Hodgkin’s disease with COPP/ABV/IMEP versus COPP/ABVD and consolidating radiotherapy: final results of the German Hodgkin’s Lymphoma Study Group HD6 trial
- W4247397165
- Symptomatic osteonecrosis as a treatment complication in Hodgkin lymphoma: an analysis of the German Hodgkin Study Group (GHSG)